Administration of clodronate- (Cl2MDP) encapsulated liposomes partially depleted TAMs (defined as F4/80- and CD68-positive cells on immunohistochemical staining), resulting in reduced tumor growth in a murine Hepa1-6 cell-transplanted tumor model. This evidence concerns the gene CD68 and neoplasm.